Proteolysis-targeting chimeras (PROTACs) and molecular glue degraders (MGDs) are one of the most maturely formulated TPD approaches. During this evaluate, we center on both equally preclinical experiments and medical trials to supply a comprehensive summary of the security and clinical success of PROTACs and MGDs in hematologic malignancies in the https://pablop530glo3.vidublog.com/profile